TOKYO, Japan, October 10, 2023 — CarbGeM Inc, a Japan-based startup focused on AI-based diagnostics, today announced four presentations addressing the problem of Antimicrobial Resistance (AMR) will be featured at the IDWeek taking place, October 11-15, 2023, in Boston.
Featured presentations include pre-clinical and early clinical results from the company’s ongoing study of the AI-based smartphone app, BiTTE, which estimates the bacterial species in a Gram-stained sample, as well as a new thin-film transistor (TFT) image sensor that monitors bacterial growth on agar plates.
Details of the poster presentations are as follows (all time in EDT):
Title: Research and Development of Image Recognition AI to Estimate Bacterial Species using Gram Stain Findings in Aerobic and Anaerobic Blood Culture Bottle
Date/Time: Thursday, October 12 from 12:15 pm to 1:30 pm
Session P587 – 049. Diagnostics: Bacteriology/Mycobacteriology
Title: Distinguishing between drug-susceptible and resistant Neisseria gonorrhoeae from urine samples by image recognition AI.
Date/Time: Thursday, October 12 from 12:15 pm to 1:30 pm
Session P855 – 061. New Approaches to Diagnostics
Title: A New Thin-Film Transistor Image Sensor for Estimation of Bacterial Colony Species on Agar Plates
Date/Time: Thursday, October 12 from 12:15 pm to 1:30 pm
Session P590 – 049. Diagnostics: Bacteriology/Mycobacteriology
Title: Image Sensor-based Real Time Monitoring of Bacterial Growth on Agar Plates
Date/Time: Thursday, October 12 from 12:15 pm to 1:30 pm
Session P596 – 049. Diagnostics: Bacteriology/Mycobacteriology
Through the fusion of biology and digital technology, CarbGeM aims to apply its proprietary AI analysis technology to the field of bacterial infectious diseases. CarbGeM will accelerate industry-academia collaboration with domestic and overseas academia, companies, etc., and contribute to solving the global issue of drug resistance through open innovation.
For more information, please visit the company website at https://carbgem.com/en/
